August 28, 2025- Thermo Fisher Scientific Inc. is proud to receive three R&D 100 Awards for innovations designed to advance scientific discovery in critical areas like precision medicine and cell and gene therapy research and development. All three awarded products were recognized in the Analytical/Test category, which highlights breakthroughs in instrumentation, imaging, testing systems, laboratory equipment and life sciences technologies, demonstrating Thermo Fisher’s commitment to advancing groundbreaking research.
Established in 1963, the R&D 100 Awards is the only science and technology awards competition that recognizes new commercial products, technologies and materials that are available for sale or license for their technological significance. Sponsored by R&D World Magazine, the R&D 100 Awards recognize and celebrate the 100 most innovative technologies of the previous year. Now in its 63rd year, the 2025 judging panel featured 54 respected industry professionals from across the globe.
The Thermo Scientific™ Stellar™ Mass Spectrometer (MS) sets a new benchmark for precision in biomarker research. With ten times greater sensitivity when analyzing five times more compounds than traditional systems, it empowers researchers to quickly confirm and verify candidate drugs and biomarker molecules including peptides, metabolites and lipids.
The Thermo Scientific™ KingFisher™ PlasmidPro Maxi Processor (PlasmidPro) is the first fully automated system for large-scale plasmid DNA purification, delivering high-quality DNA in just 75 minutes—half the time of conventional methods. Its all-in-one cartridge design eliminates extra equipment, reduces contamination risk, and streamlines workflows.
The SteriSEQ™ Rapid Sterility Testing Kit speeds up cell therapy development while enhancing patient safety. Using advanced real-time PCR technology, it detects bacteria and fungi simultaneously with only minimal sample input, delivering reliable results in less than 24 hours.